当前位置:首页 - 行情中心 - 东方生物(688298) - 财务分析

东方生物

(688298)

  

流通市值:50.28亿  总市值:50.28亿
流通股本:2.02亿   总股本:2.02亿

东方生物(688298)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润-1.74亿元,每股收益-0.84元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益659792.68万元,未分配利润602055.30万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产761062.11万元,负债101269.43万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入403,079,827.49191,951,815.38827,916,211.63657,613,863.02
营业总成本582,106,668.08308,694,803.361,250,501,323.181,015,757,409.45
其他经营收益
营业利润-178,948,028.54-123,486,375.38-578,830,613.08-282,546,252.62
利润总额-173,109,765.94-123,574,627.79-585,310,825.22-277,687,025.51
净利润-174,059,798.07-120,770,122.94-568,822,462.49-274,227,549.6
每股收益
其他综合收益-21,826,549.14-7,821,204.512,528,352.12-17,554,233.08
综合收益总额-195,886,347.21-128,591,327.44-556,294,110.37-291,781,782.68
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计3,487,303,556.63,583,909,471.493,978,764,707.924,560,590,159.96
非流动资产:
非流动资产合计4,123,317,580.334,175,252,480.144,115,815,538.623,673,813,853.92
资产总计7,610,621,136.937,759,161,951.638,094,580,246.548,234,404,013.88
流动负债:
流动负债合计827,565,622.04886,725,492.611,203,801,573.541,113,969,480.79
非流动负债:
非流动负债合计185,128,705.46207,704,629.8299,345,516.3669,207,211.49
负债合计1,012,694,327.51,094,430,122.431,303,147,089.91,183,176,692.28
所有者权益(或股东权益):
归属于母公司股东权益合计6,460,166,977.016,521,817,616.656,645,091,305.16,880,382,859.03
股东权益合计6,597,926,809.436,664,731,829.26,791,433,156.647,051,227,321.6
负债和股东权益合计7,610,621,136.937,759,161,951.638,094,580,246.548,234,404,013.88
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计520,372,219.55276,022,567.961,137,946,642.79770,134,603.96
经营活动现金流出小计643,642,810.53330,311,178.131,486,273,498.111,137,287,458.54
经营活动产生的现金流量净额-123,270,590.98-54,288,610.17-348,326,855.32-367,152,854.58
投资活动产生的现金流量:
投资活动现金流入小计2,950,496,728.231,466,438,459.324,949,464,573.543,363,431,685.56
投资活动现金流出小计2,747,098,456.691,757,065,374.735,619,614,365.963,617,015,888.69
投资活动产生的现金流量净额203,398,271.54-290,626,915.41-670,149,792.42-253,584,203.13
筹资活动产生的现金流量:
筹资活动现金流入小计271,000,000239,000,000301,110,000291,060,000
筹资活动现金流出小计419,367,536.74368,983,199752,847,311.43666,047,236.57
筹资活动产生的现金流量净额-148,367,536.74-129,983,199-451,737,311.43-374,987,236.57
汇率变动对现金及现金等价物的影响1,645,378.843,253,774.5151,885,915.889,889,480.5
现金及现金等价物净增加额-66,594,477.34-471,644,950.07-1,418,328,043.29-985,834,813.78
期末现金及现金等价物余额1,443,680,821.541,038,630,348.811,510,275,298.881,942,768,528.39
补充资料:
现金及现金等价物的净增加额-66,594,477.34--1,418,328,043.29-
TOP↑